ExsoMed Corporation announced the INnate Intramedullary Threaded Nail has treated 5,000 metacarpal fractures, reflecting rapid uptake of ExsoMed’s technology.
INnate is designed specifically for minimally invasive fixation of metacarpal fractures, offering robust length and a dual crest height design that provides optimal fit within the intramedullary canal. Additionally, INnate is the only non-compression option, constructed to avoid shortening of oblique and comminuted fractures.
Dr. Marc Richard of Duke University Medical Center said, “The ability to treat metacarpal fractures with INnate and the intramedullary technique has been an incredible value-add to the care of my patients. I have been able to expand my indications for the nails and achieve excellent outcomes. It has become my ‘go-to’ technique for the majority of my operative metacarpal fractures.”
ExsoMed Corporation announced the INnate Intramedullary Threaded Nail has treated 5,000 metacarpal fractures, reflecting rapid uptake of ExsoMed's technology.
INnate is designed specifically for minimally invasive fixation of metacarpal fractures, offering robust length and a dual crest height design that provides optimal fit within...
ExsoMed Corporation announced the INnate Intramedullary Threaded Nail has treated 5,000 metacarpal fractures, reflecting rapid uptake of ExsoMed’s technology.
INnate is designed specifically for minimally invasive fixation of metacarpal fractures, offering robust length and a dual crest height design that provides optimal fit within the intramedullary canal. Additionally, INnate is the only non-compression option, constructed to avoid shortening of oblique and comminuted fractures.
Dr. Marc Richard of Duke University Medical Center said, “The ability to treat metacarpal fractures with INnate and the intramedullary technique has been an incredible value-add to the care of my patients. I have been able to expand my indications for the nails and achieve excellent outcomes. It has become my ‘go-to’ technique for the majority of my operative metacarpal fractures.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
